NACDS backs “partial fill” concept to curb opioid abuse

February 3, 2021 by Chain Drug Review Drug Enforcement Administration’s (DEA), NACDS, NACDS president and chief executive officer Steven Anderson Leading Headlines, Pharmacy

ARLINGTON, Va. — The Drug Enforcement Administration’s (DEA) rulemaking that implements a 2016 law allowing for the partial filling of Schedule II controlled substances is a necessary step to help address the opioid-abuse epidemic, yet changes are recommended to ensure success, NACDS said in comments to the DEA this week.   NACDS submitted its comments on a DEA notice of proposed rulemaking, which seeks to implement aspects of the Comprehensive Addiction and Recovery Act of 2016.    “Given the